1. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies;Arora;Lancet Infect. Dis.,2023
2. A guide to COVID‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV‐2 infection;Brady;FEBS J.,2022
3. Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA;Fiaschi,2022
4. SARS-CoV-2 Omicron variant: epidemiological features, biological characteristics, and clinical significance;Guo;Front. Immunol.,2022
5. Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir;Hu,2022